Skip to main content

Table 9 The gastrointestinal and genitourinary toxicity of 3DCRT, VMAT, and tomotherapy

From: The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between tomotherapy and volumetric modulated arc therapy

 

3DCRT (n = 9)

VMAT (n = 11)

Tomotherapy (n = 10)

P value

Diarrhea

Gr. 0/1

3 (33.3)

5 (45.5)

9 (90.0)

0.029

Gr. ≥ 2

6 (66.7)

6 (54.5)

1 (10.0)

 

Colitis

Gr. 0/1

7 (77.8)

9 (81.8)

8 (80.0)

0.975

Gr. ≥ 2

2 (22.2)

2 (18.2)

2 (20.0)

 

Cystitis

Gr. 0/1

6 (66.7)

4 (36.4)

7 (70.0)

0.230

Gr. ≥ 2

3 (33.3)

7 (63.6)

3 (30.0)

 
  1. 3DCRT three-dimensional conformal radiation therapy, VMAT volumetric modulated arc therapy, Gr. grade
  2. Data are presented as n (%)